1ir3
From Proteopedia
(Difference between revisions)
m (Protected "1ir3" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1ir3.png|left|200px]] | ||
| - | |||
{{STRUCTURE_1ir3| PDB=1ir3 | SCENE= }} | {{STRUCTURE_1ir3| PDB=1ir3 | SCENE= }} | ||
| - | |||
===PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG=== | ===PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG=== | ||
| - | |||
{{ABSTRACT_PUBMED_9312016}} | {{ABSTRACT_PUBMED_9312016}} | ||
Revision as of 09:51, 11 March 2013
Contents |
PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG
Template:ABSTRACT PUBMED 9312016
About this Structure
1ir3 is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Hubbard SR. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 1997 Sep 15;16(18):5572-81. PMID:9312016 doi:10.1093/emboj/16.18.5572
- Fabrega C, Hausmann S, Shen V, Shuman S, Lima CD. Structure and mechanism of mRNA cap (guanine-N7) methyltransferase. Mol Cell. 2004 Jan 16;13(1):77-89. PMID:14731396
- Iakoucheva LM, Radivojac P, Brown CJ, O'Connor TR, Sikes JG, Obradovic Z, Dunker AK. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 2004 Feb 11;32(3):1037-49. Print 2004. PMID:14960716 doi:10.1093/nar/gkh253
